SIVEXTRO

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Estonia, Finland, France, Ireland, Japan, Lithuania, Mexico, Poland, Singapore, Spain, UK.

Active ingredients

The drug SIVEXTRO contains one active pharmaceutical ingredient (API):

1	Tedizolid UNII O7DRJ6R4DW - TEDIZOLID PHOSPHATE
	Tedizolid is an oxazolidinone prodrug. The antibacterial activity of tedizolid is mediated by binding to the 50S subunit of the bacterial ribosome resulting in inhibition of protein synthesis. Tedizolid is primarily active against Gram-positive bacteria.
	Read more about Tedizolid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SIVEXTRO Powder for concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)
SIVEXTRO Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XX11		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	525519060021113, 525519060021213, 538918050028602, 538918050028702
EE	Ravimiamet	1680982, 1680993, 1681006
ES	Centro de información online de medicamentos de la AEMPS	115991001, 115991003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	036161, 066893
FR	Base de données publique des médicaments	69945545
GB	Medicines & Healthcare Products Regulatory Agency	297229, 297232
JP	医薬品医療機器総合機構	6249003F1029, 6249402D1026
LT	Valstybinė vaistų kontrolės tarnyba	1076036, 1076037, 1076038
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	144M2016, 149M2016
PL	Rejestru Produktów Leczniczych	100342559, 100342571
SG	Health Sciences Authority	14850P, 14851P
US	FDA, National Drug Code	67919-040, 67919-041